Media Center

Corporate
Henry Schein at a Glance

Media Center

Feature Story

Henry Schein recently announced that it signed an agreement to acquire Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and Mini Pharmacy in 2023, reinforcing the Company’s strategic commitment to the homecare medical supplies market. Henry Schein’s homecare medical products platform will now have an annual revenue base of approximately $350 million.

“As the delivery of health care in the U.S. is increasingly provided in home-based settings, Henry Schein is strategically expanding our offerings to meet the growing demand,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. “We are pleased to announce our acquisition of Acentus, which enhances our ability to deliver CGM products directly to patients’ homes. With Acentus, we will strengthen our position nationally in the home medical supply market and better serve our valued customers, including clinics, physician practices, health systems, ambulatory surgery centers, and most importantly, patients and families.”

Click here to read the full press release.

.

 

 

 


#RelyOnHenrySchein

Rely on Henry Schein's network of trusted advisors to help take care of your business, so you can focus on taking care of your patients.

#RelyOnHenrySchein is a new campaign that puts the spotlight on our customers. Through a collection of stories, #RelyOnHenrySchein provides health care professionals with a platform to share their unique experiences in managing productive and efficient practices.

Learn More»